Behavioural alterations in rats induced by single prenatal exposure of haloperidol

Indian Journal of Experimental Biology

Volumn 36, Issue 11, 1998, Pages 1102-1107

  Singh, K P ^a   Jaiswal, A K ^a   Singh, M ^a   Bhattacharya, S K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; GESTATIONAL AGE; MALE; METABOLISM; NERVOUS SYSTEM; PREGNANCY; PRENATAL EXPOSURE; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; FEMALE; GESTATIONAL AGE; HALOPERIDOL; MALE; MATERNAL-FETAL EXCHANGE; NERVOUS SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS;

EID: 0032200490     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Goldberg H L & DiMascio A, in Psychopharmacology: A generation of progress, edited by Lipton M A, DiMascio A, Killam K R (Raven Press, NY) 1978, 1047.
2. Spear L P, Shalaby A & Brick J, Psychopharmacology (Berl), 70 (1980) 47.
3. Shalaby I A & Spear L P, Pharmacol Biochem Behav, 13 (1980) 685.
4. Scalzo F M & Spear L P, Psychopharmacology, 35 (1985) 271.
5. Madsen J R, Campbell A & Baldessarini R J, Psychopharmacology 73 (1981) 219.
6. Singh Y, Jaiswal A K, Singh M & Bhattacharya S K, Indian J Exp Biol, 35 (1997) 1284.
7. Jurand A & Martin LV H, Teratology, 42 (1990) 45.
8. Holson R R, Webb P J, Grafton T H & Hansen D K, Teratology, 50 (1994) 125.
9. Bronstein P M, J Comp Physiol Psychol, 80 (1972) 335.
10. Pellow S & File S E, Pharmacol Biochem Behav, 24 (1986) 525.
11. Martin P, Soubrie P & Simon P, Prog Neuropsychopharmacol Biol Psychiat, 11 (1987) 1.
12. Sherman A D & Petty F, Behav Neur Biol, 35 (1982) 344.
13. Martin P, Soubrie P & Simon P, Pharmacol Biochem Behav, 2 (1986) 177.
14. Seigel S, Non-parametric statistics for the behavioural sciences, (McGraw-Hill, NY, 1956).
15. Ahlenius S, Engel J, Hoard E, Larsson K, Lundborg P & Sinnerstedt P, Pharmacol Biochem Behav, 6 (1977) 343.
16. Kleinberg N & Yanai J, Dev Brain Res, 22 (1985) 113.
17. Middaugh L D, Thomas T N, Simpson L W & Zemp T, Neurobehav Toxicol Teratol, 3 (1981) 271.
18. Middaugh L D, Blackwell L A & Santos C A, Dev Psychobiol, 7 (1974) 429.
19. Ransom B R & Elmore J G, Adv Neurol, 55 (1991) 225.
20. Singh Y, Jaiswal A K, Singh M & Bhattacharya S K, Indian J Exp Biol, 34 (1996) 1095.
21. Werboff J, Gottlieb J S, Havlena J & Word T J, Pediatrics, 27 (1961) 318.
22. Kellogg C K, Prion R J & Bisan D L, J Pharmacol Exp Ther 256 (1990) 259.
23. File S E, in Selected models of anxiety, depression and psychosis, edited by Simon P, Soubric P & Wildlocher D, (Karger, Basel) 1988, 151.
24. Zhang J, Wang L & Pitts D K, Neurotoxicol Teratol, 18 (1996) 49.
25. Scalzo F M, Holson R R, Gough B J & Ali S F, Pharmacol Biochem Behav, 3 (1989) 721.
26. Kellogg C K, Prog Brain Res, 73 (1988) 207.
27. Friedhoff A J & Miller J C, in Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic transmitter systems, edited by Schlumpf M, Lichtenstiger W (Karger, Basel) 1983, 91.
28. Giorgi O, DeMontis G, Porceddu M L, Mele S, Calderini G, Toffano G & Biggio G, Dev Brain Res, 35 (1987) 283.
29. Rosengarten H, Friedman E & Friedhoff A J, in Nervous system regeneration, edited by Guiffrida - Stella AM, Haber B, Hashim G, Perez-Polo (Alan Liss, N Y) 1983, 511.
30. Shaywitz B A, Yager R D & Klopper J H, Science, 191 (1976) 305.
31. Miller E F, Hefner T G, Kotake C & Seiden L S, Brain Res, 229 (1981) 123.
32. Stahl S M & Palazidou L, TIPS, 7 (1986) 349.
33. Curzon G, Clin Neuropharmacol, Suppl 2 (1988) S 11.
34. Wallace S J, in Neurobehavioural teratology, edited by Yanai J (Elsevier Science, BV) 1984, 133.